Sign in

CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company

Ovid Therapeutics Inc.

Sign in to watch
Ticker
OVID
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465270895
Phone
212-776-4381
Business address
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy CEO bought 8,488 shares at $5.84 ($49,570)
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Open-market buy 10% owner bought 2,000,000 shares at $2.50 ($5,000,000)
  20. 3 Insider Initial Statement of Ownership

Page 6 of 10 · 182 filings